Riunet Móvil
Home
Versión de escritorio
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop
Mostrar el registro completo del ítem
Título:
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop
Autor:
Bover, Isabel; Rolfo, Christian; Jantus Lewintre, Eloisa; Sirera Pérez, Rafael; Camps, Carlos; Chaib, Imane; Ramirez-Serrano, Jose L.; Benlloch, Susana; Molina-Vila, Miguel Angel; Simonetti, Sara; Costa, Carlota; Gimenez-Capitan, Ana; Mendez, Pedro; Taron, Miguel; Rosell, Rafael
Resumen:
The majority of non-small-cell lung cancer (NSCLC) patients present with locally advanced (35%) or metastatic disease (40%); in this setting, it is of the utmost importance to balance efficacy with toxicity. However, with platinum combinations, survival has reached a " plateau" , with median overall survival times of a mere 10-12 months, making it mandatory to search for new strategies and to identify more effective treatment. Molecular characteristics can be more informative than clinical features in predicting clinical benefit, and the identification of molecular markers can help define subgroups of patients who are likely to respond to different treatments, thus avoiding unnecessary toxicities and costs and providing the maximum benefit to each patient. Here we review research on biomarker assessment that was presented during the Molecular Biology Workshop held in Palma de Mallorca on 25 November 2010, during the Fifth Educational Symposium of the Spanish Lung Cancer Group. © 2011.
URI:
http://hdl.handle.net/10251/77413
Fecha:
2011-12
Relacionado
Ítems en Google Scholar
Ficheros en el ítem
Descargar (628.8Kb)
Jantus;Sirera -...c....pdf
PDF
Este ítem aparece en la(s) siguiente(s) colección(ones)
Artículos, conferencias, monografías
[47689]
Mostrar el registro completo del ítem
Related items
Showing items related by title, author, creator and subject.
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients
Sirera Pérez, Rafael
(
Elsevier
,
2011-07
)
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
Camps, Carlos
;
Jantus Lewintre, Eloisa
;
Cabrera, Andrea
;
Blasco, Ana
;
Sanmartin, Elena
;
Gallach, Sandra
;
Caballero, Cristina
;
del Pozo, Nieves
;
Rosell, Rafael
;
Guijarro, Ricardo
;
Sirera Pérez, Rafael
(
Elsevier
,
2011-06
)
Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients
Jantus Lewintre, Eloisa
;
Sirera Pérez, Rafael
;
Cabrera, Andrea
;
Blasco, Ana
;
Caballero, Cristina
;
Iranzo, Vega
;
Rosell, Rafael
;
Camps, Carlos
(
Elsevier
,
2011-09
)
Tema móvil para Riunet